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Introduction
The human APOBEC (apolipoprotein B mRNA editing catalytic 
polypeptide-like) family includes enzymes that catalyze the 
hydrolytic deamination of cytidine to uridine or deoxycytidine to 
deoxyuridine. This family is composed of eleven known members: 
APOBEC1, APOBEC2, APOBEC3 (further classified as A3A 
to A3H), APOBEC4, and AID (activation induced deaminase). 
APOBEC proteins are associated with several functions involving 
editing of DNA or RNA (reviewed by Smith et al1). APOBEC1 
mediates deamination of cytidine at position 6666 of apolipo-
protein B mRNA, resulting in the introduction of a premature 
stop codon and the production of the short form of the protein2–4. 
APOBEC2 is essential for muscle tissue development5. APOBEC4 
has no ascribed function so far6. AID deaminates genomic ssDNA 
of B cells, initiating immunoglobulin somatic hypermutation and 
class switch processes7–9. Most notably, APOBEC3 enzymes par-
ticipate in innate immunity against retroviruses and endogenous 
retroelements10–12. Sheehy et al. demonstrated that A3G also plays 
a role in immunity against human immunodeficiency virus type 
1 (HIV-1)13. For its antiviral role, A3G is packaged along with 
viral RNA14. Upon infection of target cells and during the reverse 
transcription process, A3G deaminates the cytosine residues of 
the nascent first retroviral DNA strand into uraciles. The resulting 
uracil residues serve as templates for the incorporation of adenine, 
which at the end result in strand-specific C/G to T/A transitions 
and loss of infectivity through lethal mutagenesis15–19. On the 
other hand, sub-lethal mutagenic activity of APOBEC3 proteins 
may end up being an additional source for HIV-1 genetic diver-
sity, hence bolstering its evolvability20–22. APOBEC3 proteins have 
been shown to inhibit other retroviruses (simian immunodeficiency 
virus23, equine infectious anemia virus24, foamy virus25, human 
T-cell leukemia virus26, and murine leukemia virus27), pararetro-
viruses (hepatitis B virus28) and DNA viruses (herpes simplex 
virus 129,30, Epstein-Barr virus30, HSV-1 and EBV respectively, and 
human papillomavirus31). In the cases of HSV-1 and EBV, the 
antiviral role of deaminases has not yet been demonstrated30.
Evidence also exists that A3G significantly interferes with 
negative-sense RNA viruses lacking a DNA replicative phase32. 
For example, the transcription and protein accumulation of 
measles virus, mumps virus and respiratory syncytial virus 
(RSV) was reduced 50–70%, whereas the frequency of C/G 
to U/A mutations was ~4-fold increased after overexpressing 
A3G in Vero cells32. In contrast, A3G plays no antiviral activity 
against influenza A virus despite being highly induced in infected 
cells as part of a general IFN-β response to infection33,34.
Human APOBEC belongs to a superfamily of polynucleotide cytidine 
and deoxycytidine deaminases distributed throughout the biological 
world35. All family members contain a zinc finger domain (CDD), 
identifiable by the signature (H/C)-x-E-x25-30P-C-x-x-C. Plants 
are not an exception and, for example, the Arabidopsis thaliana 
genome encodes nine putative cytidine deaminases (with genes 
named AtCDA1 to AtCDA9). Whilst the AtCDA1 gene is located in 
chromosome II, the other eight genes are located in chromosome 
IV. In the case of rice and other monocots, only one CDA has been 
identified35. Interestingly, this CDA expression was highly induced 
as part of the general stress response of rice against infection of the 
fungal pathogen Magnaporthe grisea, resulting in an excess of A to 
G and U to C mutations in defense-related genes36. Edited dsRNAs 
might be retained in the nucleus and degraded, generating miRNAs 
and siRNAs37. Given the relevance of deamination as an antiviral 
innate response in animals, we sought first to determine whether any 
of the AtCDA proteins encoded by plants can participate in deami-
nating the genome of the pararetrovirus, cauliflower mosaic virus 
(CaMV; genus Caulimovirus, family Caulimoviridae) and, second, 
we sought to explore whether this deamination may negatively 
impact viral infection. We hypothesize that deamination may take 
place mainly at the reverse transcription step. The CaMV genome is 
constituted by a single molecule of circular double-stranded DNA 
of 8 kbp38. The DNA of CaMV has three discontinuities, Δ1 in the 
negative-sense strand (or a strand), and Δ2 and Δ3 in the positive-
sense strand (yielding the b and g strands). In short, the replication 
cycle of CaMV is as follows38: in the nucleus of the infected cell, 
the a strand is transcribed into 35S RNA, with terminal repeats, 
that migrates to the cytoplasm. Priming of the 35S RNA occurs by 
the annealing of the 3’ end of tRNAmet to the primer-binding site 
(PBS) sequence, leading to the synthesis of the DNA a strand by the 
virus’ reverse transcriptase. Then, the RNA in the heteroduplex is 
degraded by the virus’ RNaseH activity, leaving purine-rich regions 
that act as primers for the synthesis of the positive-sense DNA b 
and g strands.
Our results show that AtCDA1 significantly increases the number 
of G to A mutations in vivo, and that there is a negative correla-
tion between the amount of AtCDA1 mRNA present in the cell and 
the load reached by CaMV, suggesting that deamination of viral 
genomes may also constitute a significant antiviral mechanism in 
plants.
Methods
Transient overexpression of AtCDAs in Nicotiana bigelovii 
plants infected with CaMV
AtCDAs cDNAs were cloned under the 35S promoter in a 
pBIN61 vector39. N. bigelovii plants were inoculated with 
CaMV virions purified from Brassica rapa plants40 previously 
infected with the clone pCaMVW26041. N. bigelovii was chosen for 
            Amendments from Version 1
In response to Reviewer 1, we have (i) specified the number of 
half-leafs per plant that were agroinfiltrated with each of the nine 
AtCDAs, (ii) mention in the Discussion the possibility of whether a 
low threshold in the number of G to A transition would be enough 
as to trigger the antiviral mutagenic effect, (iii) added extra text to 
the Discussion commenting on the synonymous/nonsynonymous 
nature of the mutations observed during the agroinfiltration 
experiments with the AtCDA1. Supplementary Table S1 has been 
also modified accordingly.
In response to Reviewer 2, we have (i) added text in the Material 
& Methods section to justify our choice of N. bigelovii for the 
agroinfiltration experiments, (ii) rewrite some passages to make 
clear that our results only suggest a potential antiviral role for 
AtCDA1, (iii) added a new paragraph to the Discussion on the 
potential antiviral role of CDAs in other viral systems.
In addition, we are now citing in the discussion a highly relevant 
reference by Chen et al. 2016 that was published very recently.
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this particular experiment for practical reasons: it is susceptible to 
CaMV infection, while Nicotiana benthamiana is not, and it is eas-
ily agroinfiltrated. Three symptomatic leafs were agroinfiltrated39 
with one of the nine AtCDAs and with the empty vector pBIN61, 
each on one half of the leaf. Samples were collected three days 
post-agroinfiltration.
Inducible co-suppression of multiple AtCDAs by RNAi
The design and cloning of the artificial micro-RNA (amiR) able to 
simultaneously suppress the expression of AtCDAs 1, 2, 3, 4, 7, and 
8 was performed as described in ref. 42. The amiRNA was cloned 
under the control of Aspergillus nidulans ethanol regulon43,44 and 
used to transform A. thaliana by the floral dip method45. By doing 
so, we obtained the transgenic line amiR1-6-3. One-month-old 
seedlings of transgenic and wild-type A. thaliana were treated 
with 2% ethanol (or water for the control groups) three times 
every four days. Three days after the third treatment, plants were 
inoculated with the infectious clone pCaMVW260 as described 
in ref. 41. Infections were established by applying 1.31×1011 
molecules of pCaMVW260 to each of three leaves per plant. 
Subsequently, plants were subjected to two additional treatments 
with 2% ethanol (or water) one and five days post-infection. Finally, 
samples were taken eight days after inoculation and handled as 
previously described46. For each genotype (transgenic or wild-
type) and treatment (ethanol or water) combination, 22 plants were 
analyzed.
Detection of A/T enriched genomes
CaMV genomic DNA was purified using DNeasy Plant Mini Kit 
(Qiagen) according to manufacturer’s instructions. For detection of 
edited genomes 3D-PCR was performed using primers HCa8Fdeg 
and HCa8Rdeg. PCRs were performed in a Mastercycler® 
(Eppendorf) at denaturation temperatures 82.1°C, 82.9°C, 83.9°C, 
and 85.0°C. The 229 nt long PCR products obtained with the lowest 
denaturation temperature were cloned in pUC19 vector (Fermentas), 
transformed in Escherichia coli DH5α and sent to GenoScreen 
(Lille, France) for sequencing.
RT-qPCR analysis of AtCDA1 mRNA and qPCR analysis 
of CaMV load in transgenic plants
Total RNA was extracted from A. thaliana plants using the 
RNeasy® Plant Mini Kit (Qiagen), according to manufacturer’s 
instructions. AtCDA1 specific primers qCDA1-F and qCDA1-R 
were designed using Primer Express software (Applied Biosystems). 
RT-qPCR reactions were performed using the One Step SYBR 
PrimeScript RT-PCR Kit II (Takara). Amplification, data acquisi-
tion and analysis were carried out using an Applied Biosystems 
Prism 7500 sequence detection system. All quantifications were 
performed using the standard curve method. To quantify AtCDA1 
mRNA, a full-ORF runoff transcript was synthetized with T7 RNA 
polymerase (Roche) using as template a PCR product obtained from 
cloned AtCDA1 and primers T7-CDA1F and qCDA1-R. CaMV 
qPCR quantitation was performed as described in ref. 46.
Primers
All primers used are listed in Supplementary Table S3.
Results
Effect of AtCDAs overexpression on CaMV mutational 
spectrum
To test the mutagenic activity of A. thaliana CDAs, nine N. bigelovii 
plants were inoculated with CaMV. After systemic infection was 
established, we performed transient AtCDA overexpression experi-
ments. To do so, the same leaf was agroinfiltrated twice; one half 
of the leaf was infiltrated with one of the nine AtCDA genes and the 
other half of the leaf was infiltrated with the empty vector. This test 
was done for all nine AtCDA genes in different plants. The presence 
of AtCDA mRNAs was verified by RT-PCR from DNase-treated 
RNA extracts. DNA was extracted from agroinfiltrated areas for 
3D-PCR amplification of a 229 bp fragment in the ORF VII of 
CaMV. 3D-PCR uses a gradient of low denaturation temperatures 
during PCR to identify the lowest one, which potentially allows 
differential amplification of A/T rich hypermutated genomes47. 
There were no differences in the lowest denaturation tempera-
ture that could result in differential amplification of controls and 
the AtCDA-agroinfiltrated samples, suggesting that hypermutated 
genomes should be at low frequency, if present at all.
PCR products obtained at the lowest denaturation temperature were 
cloned and sequenced. In a preliminary experiment, we sequenced 
25 clones from each AtCDA/negative control pair (Supplementary 
Table S1). At least one G to A transition was detected in clones 
from areas infiltrated with AtCDA1, AtCDA2 and AtCDA9 genes. 
For these three genes, we further increased the number of sequenced 
clones up to 106. The CaMV mutant spectra was significantly 
different between plants overexpressing AtCDA1 and their respec-
tive negative controls (Figure 1a: χ2 = 25.760, 7 d.f., P = 0.001). 
This difference was entirely driven by the 471.43% increase in G 
to A transitions observed in the plants overexpressing AtCDA1. A 
thorough inspection of alignments showed that most of the G to A 
mutations (65.6%) detected in the different samples were located 
at the nucleotide position 181 (Supplementary Table S1). By 
contrast, no overall difference existed between the mutant spectra 
of CaMV populations replicating in plants overexpressing AtCDA2 
(Figure 1b: χ2 = 8.944, 6 d.f., P = 0.177) or AtCDA9 (Figure 1c: 
χ2 = 6.539, 8 d.f., P = 0.587) and their respective controls. Con-
sistently, the mutant spectra from the three AtCDA-overexpressed 
samples were significantly heterogeneous (χ2 = 41.063, 16 d.f., 
P = 0.001), again due to the enrichment in G to A transitions 
observed in the case of AtCDA1. By contrast, the three independent 
control inoculation experiments showed homogeneous mutant 
spectra for CaMV (χ2 = 14.605, 18 d.f., P = 0.689), undistinguish-
able from the mutant spectra previously reported for natural iso-
lates of this virus48. The consistency of the mutant spectra observed 
for the three control experiments and with the spectrum described 
for a natural isolate of the virus suggests that under the physio-
logical expression level of AtCDA1, the CaMV mutant spectrum is 
rather stable.
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Figure  1.  Number  of  mutations  in  CaMV  genomes  isolated  from  plant  tissues  agroinfiltrated  with  different  AtCDAs.  (a) AtCDA1, 
(b) AtCDA2 and (c) AtCDA9. The pBIN61 empty vector was agroinfiltrated in the same leaves than their corresponding AtCDAs (mock). For 
each sample 20,034 nucleotides were sequenced.
We conclude that overexpressing the AtCDA1 gene results in a 
significant shift in CaMV genome composition towards G to A 
mutations, as expected from cytidine deaminase hypermutagenic 
activity.
Effect of suppressing AtCDA expression on the viral load 
and mutational spectrum of CaMV
To test the effects of suppressing the expression of AtCDA on viral 
accumulation we produced a transgenic line of A. thaliana Col-0, 
named amiR1-6-3. This line was stably transformed with an amiR, 
controlled by the A. nidulans ethanol regulon to achieve ethanol-
triggered RNAi-mediated simultaneous suppression of AtCDAs 
1, 2, 3, 4, 7, and 8 expression. Transgenic and wild-type plants 
were subjected to periodical treatment with 2% ethanol (or water 
for the control groups). Subsequently, plants were inoculated with 
the infectious clone pCaMVW260 that expresses the genome of 
CaMV. Samples were taken eight days after inoculation and 
AtCDA1 mRNA and CaMV viral load were quantified by real time 
RT-qPCR and qPCR, respectively, in the same samples. For each 
genotype and/or treatment, 22 plants were analyzed.
The expression of AtCDA1 mRNA depended on the plant genotype 
(Figure 2a; GLM: χ2 = 28.085, 1 d.f., P < 0.001) as well as on the 
interaction of plant genotype and treatment (χ2 = 26.037, 1 d.f., 
P < 0.001), suggesting a differential accumulation of AtCDA1 
mRNA on each plant genotype depending on the amiR1-6-3 
induction state. Ethanol treatment reduced the amount of AtCDA1 
mRNA by 24.01% in transgenic plants, proving that triggering the 
expression of the amiR1-6-3 significantly and efficiently silences 
the expression of AtCDA1. Unexpectedly, the effect was the oppo-
site in wild-type plants, for which we observed 23.76% increase 
in AtCDA1 mRNA accumulation (Figure 2a) upon treatment 
with ethanol. This increase in expression of AtCDA1 in wild-type 
plants after ethanol treatment and the underlying mechanisms cer-
tainly deserve to be investigated further. However, for the purpose 
of this study, its relevance is that it may increase the number of 
G to A mutations in the CaMV genome, thus making the antiviral 
effect stronger to some extent.
More interestingly, the relative accumulation of CaMV in etha-
nol-treated plants was significantly different, depending on the 
plant genotype being infected (Figure 2b; Mann-Whitney U test, 
P = 0.002): silencing the AtCDA1 gene bolstered CaMV accu-
mulation to 103.10% compared to the accumulation observed in 
wild-type plants. Furthermore, there was a significant negative cor-
relation between the number of molecules of AtCDA1 mRNA and 
viral load (partial correlation coefficient controlling for treatment: 
r = −0.299, 86 d.f., P = 0.005).
Given the significant increase of viral load in plants with lower 
levels of AtCDA1 mRNA, we sought the molecular signature 
of deamination in transgenic plants. For this, we selected three 
biological replicates from each treatment group (ethanol or control) 
and sequenced between 39–45 clones of the CaMV fragment from 
each replicate. As shown in Figure 3, silencing of the AtCDA1 gene 
affects the composition of CaMV mutant spectrum by reducing 
the number of G to A transitions by 69.23%. Nevertheless, overall, 
both mutational spectra were not significantly different (Figure 3: 
χ2 = 9.108, 6 d.f., P = 0.168), prompting caution against making 
a definite conclusion on the role of deamination in the observed 
increase in CaMV accumulation.
We conclude that suppressing the expression of the AtCDAs 1, 2, 
3, 4, 7, and 8 significantly reduces the accumulation of CaMV. 
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Figure 2. Accumulation of AtCDA1 mRNA molecules and CaMV 
genomes. (a) Number of AtCDA1 mRNA molecules/80 ng total 
RNA quantified by RT-qPCR using the standard curve method for 
absolute quantification. (b) Number of CaMV genomes/80 ng total 
DNA. For each block of plants (wild-type and amiR1-6-3), values 
were normalized to the average number of genomes estimated in 
the corresponding water-treated (control) plants.
However, the characterization of the mutant spectrum of the same 
CaMV populations provides no strong enough support to the cyti-
dine deamination hypothesis.
Discussion
Lethal mutagenesis through deamination of RNA/DNA by cytidine 
deaminases has been proven to work as an antiviral mechanism 
against retroviruses16–19,23–27, and some DNA28–31 and RNA32 viruses 
infecting mammals. Our results show that the A. thaliana CDA1 gene 
has some degree of mutagenic activity on the pararetrovirus CaMV 
genome. Moreover, simultaneously suppressing the expression 
of a subset of AtCDAs, including AtCDA1, increased CaMV load, 
strongly suggesting an antiviral role for AtCDAs. This role of 
AtCDA1 is congruent with the very recent observation by Chen 
et al. that only the product of AtCDA1 is required for in vivo home-
ostasis of pyrimidines while the other eight members of the gene 
family may be pseudogenes49
Our data show that AtCDAs probably restrict CaMV replication 
through a process similar to the restriction of HIV-1 by APOBEC3. 
CaMV replicates in the cytoplasm by reverse transcription using the 
positive-sense 35S RNA as template. As for HIV-1, the first strand 
negative-sense cDNA could be deaminated during reverse transcrip-
tion, transforming deoxycytidine into deoxyuridine. Then, when 
the positive-sense strand is produced, an A is incorporated instead 
of a G, increasing the proportion of G to A mutations. In the case 
of HIV-1, this G to A mutational bias is explained by A3G and A3H 
specificity for single negative stranded DNA: during HIV-1 replica-
tion, C to G transitions are rare and restricted to the PBS site and U3 
regions in the 5’ long terminal repeat, where positive-stranded DNA 
is predicted to become transiently single stranded50. Similarly, dur-
ing CaMV replication the negative strand remains single stranded, 
while the positive is copied from it and remains double stranded51. 
Surprisingly, for AtCDA1, C to T mutations were also increased; the 
region studied here is close to the 5’ end of CaMV, which contains 
the PBS for negative-strand synthesis and the ssDNA discontinuity 
Δ1. The observed C to T transitions could reflect transient positive-
stranded ssDNA in the 5’ terminal region during reverse transcrip-
tion, nevertheless a different substrate specificity of A. thaliana 
CDAs cannot be ruled out.
Evidences from studies with different mammalian viruses sug-
gest that APOBEC enzymes may have an antiviral role not only 
against DNA viruses and retroviruses but also against some RNA 
viruses32. Our evidences for a potential antiviral role of a plant CDA 
is restricted to the case of a pararetrovirus and thus the question 
is whether this mechanism would also operate against other types 
of plant viruses. Lin et al. described the spectrum of mutations 
accumulated in a non-coding sequence artificially inserted in the 
genome of turnip mosaic virus (TuMV), a prototypical RNA plant 
virus, during infection of N. benthamiana plants52. C to A and C 
to U transitions were significantly over represented in the mutant 
spectrum, and the authors already suggested this bias was compat-
ible with TuMV genome being edited by CDA enzymes52.
Most of the G to A transitions detected in agroinfiltration experi-
ments were located in the G at position 181. HIV-1 hypermu-
tated genomes show mutational hot spots as well, which are due 
to preference of A3G and A3F for deamination of the third C in 
5’-CCC (negative-strand) and 5’-GGC, respectively53,54. The 
sequence context of the C complementary to G181 (5’-GGC) 
differs from what has been described for APOBEC3 as hotspot 
for deamination, suggesting that if AtCDAs had a context pref-
erence, it would be different from the one described for A3G. 
However, given the low number of mutations found, we should 
be cautious when concluding whether AtCDAs have a possi-
ble sequence-context preference. Since our experiments were 
performed in vivo, negative selection is expected to purge genomes 
carrying deleterious mutations. To explore this possibility, we have 
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Figure 3.  Number of mutations found pooling the CaMV sequences from ethanol-treated and control amiR1-6-3 plants (3 replicates). 
The number of nucleotides sequenced was 23,436 for control and 24,003 for ethanol-treated plants. Ethanol-treated plants turn on the 
expression of amiR1-6-3 that was designed to silence the expression of the AtCDA1 gene.
checked the consequence of mutations in the protein encoded by 
the ORF VII (Supplementary Table S1) for the case of plant agroin-
filtrated with AtCDA1 and its corresponding paired control. Eight 
out of the 22 different mutations observed in CaMV populations 
replicating in presence of AtCDA1 were nonsynonymous, thus 
in agreement with previous observations that most G to A transi-
tions in CaMV are synonymous54. Two remarks can be made about 
these numbers.  First, quite surprisingly, six of these eight nonsyn-
onymous mutations resulted in stop codons affecting two different 
positions (amino acids C58 and Y71). Second, transition G181A 
is synonymous. For CaMV replicating in the corresponding con-
trol half-leaf (agroinfiltrated with the empty pBIN61 vector), three 
out of the 14 different mutations observed were nonsynonymous, 
one of them also resulting in an stop in codon 58. No significant 
differences exist among the relative ratio of nonsynonymous 
to synonymous mutations in both samples (Fisher’s exact test 
P = 0.467). Despite the mutagenic effect of AtCDA1 over the CaMV 
population, the number of nonsynonymous mutations relative 
to the number of synonymous mutations is not altered, thus sug-
gesting negative selection works, at least, as efficiently as it does 
in the control population. The same conclusion is reached if we 
only focus the comparison in the number of nonsynonymous 
mutations resulting in stop codons. This potential purifying 
effect of selection could account for our failure to detect largely 
hypermutated genomes, and demonstrates the need for 
developing new selection-free assays to further characterize 
AtCDA-induced mutagenesis. Despite the apparent low number 
of deamination mutations observed, it has a significant impact in 
CaMV accumulation (Figure 2b), thus suggesting that a low thresh-
old of G to A transition bias may be enough to lead to a reduction 
in viral load.
Although there is not a demonstrated correlation between the 
expression of APOBEC3 and mutational bias of viruses infecting 
mammals, caulimoviruses have an excess of G to A transitions 
in synonymous positions55. In A. thaliana plants, we found that 
silencing of AtCDA1 reduced the frequency of G to A transitions 
in the CaMV genome, suggesting a contribution of AtCDAs to 
the nucleotide bias found in caulimoviruses. The increased viral 
load in CDA-silenced A. thaliana plants strongly suggests that 
deamination of viral genomes may work as an antiviral 
mechanism in plants, leading to questions about how general this 
mechanism might be, and how it may contribute to viral evolution. 
Describing a new natural antiviral mechanism in plants opens 
new research avenues for the development of new durable control 
strategies.
Data availability
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LabArchives with DOI: 10.6070/H4TD9VD5.
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shown in Figure 1. 
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